awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37022524-55262F0D-48E5-4952-9C28-A8E2D107C98B
Q37022524-55262F0D-48E5-4952-9C28-A8E2D107C98B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-55262F0D-48E5-4952-9C28-A8E2D107C98B
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
P2860
Q37022524-55262F0D-48E5-4952-9C28-A8E2D107C98B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-55262F0D-48E5-4952-9C28-A8E2D107C98B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed96b645c7820814dddccb86ac36d3c7a69f9586
P2860
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.